Relation of Cytochrome P450 2C19 Loss-of-Function Polymorphism to Occurrence of Drug-Eluting Coronary Stent Thrombosis

References

Page 1

	Year	Citations
Aspirin-Resistant Thromboxane Biosynthesis and the Risk of Myocardial Infarction, Stroke, or Cardiovascular Death in Patients at High Risk for Cardiovascular Events John W. Eikelboom, Jack Hirsh, Jeffrey I. Weitz, Circulation	2002	1K
Influence of Omeprazole on the Antiplatelet Action of Clopidogrel Associated With Aspirin Martine Gilard, Arnaud Bertrand, Jean‐Christophe Cornily, Journal of the American College of Cardiology ThrombopoiesisMolecular PharmacologyThrombosisBlood PlateletPharmacology	2008	1K
The major genetic defect responsible for the polymorphism of S-mephenytoin metabolism in humans. S.M. de Morais, G. Wilkinson, Joyce Blaisdell, Journal of Biological Chemistry	1994	952
Cytochrome P450 2C19 loss-of-function polymorphism is a major determinant of clopidogrel responsiveness in healthy subjects Jean‐Sébastien Hulot Blood	2006	925
Variability in platelet responsiveness to clopidogrel among 544 individuals Victor L. Serebruany, Steven R. Steinhubl, Peter B. Berger, Journal of the American College of Cardiology ThrombopoiesisThrombosisCardiovascular DiseaseBlood PlateletHematology	2005	776
Common polymorphisms of CYP2C19 and CYP2C9 affect the pharmacokinetic and pharmacodynamic response to clopidogrel but not prasugrel John T. Brandt, Sandra Close, Stephen J. Iturria, Journal of Thrombosis and Haemostasis MedicineGeneticsPharmacodynamic ResponseCommon PolymorphismsPharmacogenomics	2007	726
Impact of Platelet Reactivity After Clopidogrel Administration on Drug-Eluting Stent Thrombosis Piergiovanni Buonamici, Rossella Marcucci, Angela Migliorini, Journal of the American College of Cardiology ThrombopoiesisThrombosisCardiovascular DiseaseBlood PlateletDrug-eluting Stent Thrombosis	2007	655
Prognostic significance of post-clopidogrel platelet reactivity assessed by a point-of-care assay on thrombotic events after drug-eluting stent implantation Matthew J. Price, Sarah Endemann, Raghava Gollapudi, European Heart Journal	2008	647
Cytochrome P450 2C19 681G>A Polymorphism and High On-Clopidogrel Platelet Reactivity Associated With Adverse 1-Year Clinical Outcome of Elective Percutaneous Coronary Intervention With Drug-Eluting or Bare-Metal Stents Dietmar Trenk, Willibald Hochholzer, Martin F. Fromm, Journal of the American College of Cardiology ThrombosisPercutaneous Coronary InterventionCardiovascular DiseaseBlood PlateletMyocardial Infarction	2008	543
Low response to clopidogrel is associated with cardiovascular outcome after coronary stent implantation Tobias Geisler, Harald F. Langer, Magdalena Marta Wydymus, European Heart Journal	2006	484

Page 1